Last reviewed · How we verify

Hyperbolic tapering

Universita di Verona · FDA-approved active Small molecule

Hyperbolic tapering is a dosing strategy that reduces medication dose according to a hyperbolic mathematical function rather than linear reduction.

Hyperbolic tapering is a dosing strategy that reduces medication dose according to a hyperbolic mathematical function rather than linear reduction. Used for General dosing strategy applicable to various medications requiring gradual discontinuation.

At a glance

Generic nameHyperbolic tapering
SponsorUniversita di Verona
ModalitySmall molecule
PhaseFDA-approved

Mechanism of action

Hyperbolic tapering represents a non-linear approach to dose reduction where the rate of dose decrease slows over time, following a hyperbolic curve. This contrasts with linear tapering where dose reductions occur at constant intervals. The strategy is designed to minimize withdrawal effects and physiological disruption by allowing the body to gradually adapt to lower drug concentrations.

Approved indications

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results